KRX/001060 (KRX/001060)

Korea Stock Exchange: KRX/001060 · KRW

₩26,600

-149.80 (-0.6%)· Recorded snapshot

Market cap	607.4B
Revenue (ttm)	820.9B
Net income (ttm)	97.5B
EPS (ttm)	₩4,326
Shares out	22.9M
P/E (trailing)	6.1x
Dividend	₩450 (1.62%)
Volume	20,481
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 820.9B
Net income (ttm): 97.5B
EPS (ttm): ₩4,326
P/E (trailing): 6.1x
Market cap: 607.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/En/a

P25 7.2P50 11.3P75 24.4

Trailing P/E6.1

P25 7.9P50 14.3P75 25.9

ROE27.6

P25 -16.6P50 0.8P75 9.3

ROIC25.3

P25 -10.2P50 1.4P75 6.7

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All KRX/001060 indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

KRW

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	1,067
Enterprise value	KRW 577.1B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	20.54
Industry PE Fwd	20.3
Isin	KR7001060003
Last refreshed	2026-09-13
Market cap	KRW 607.4B
Price	KRW 26,600
Price currency	KRW
Rev Per Employee	769,317,601.14x
Sector	Healthcare
Sector PE	52.81
Sector PE Fwd	27.79
Sic	2834
Symbol	krx/001060
Website	https://www.jw-pharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	16.06%
EV Earnings	5.92x
EV/EBIT	5.24x
EV/EBITDA	4.45x
EV/FCF	4.7x
EV/Sales	0.7x
FCF yield	20.22%
P/B ratio	1.48x
P/E ratio	6.15x
P/S ratio	0.74x
PE Ratio3 Y	13.68x
PE Ratio5 Y	23.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.13%
EBITDA Margin	15.51%
FCF margin	14.96%
Gross margin	47.29%
Gross Profit	KRW 388.2B
Gross Profit Growth	12.79%
Gross Profit Growth Q	16.14%
Gross Profit Growth3 Y	6.9%
Gross Profit Growth5 Y	13.09%
Net Income	KRW 97.5B
Net Income Growth	94.6%
Net Income Growth Qo Q	1.49%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	25.11%
Pretax Margin	14.05%
Profit Margin	12.34%
Profit Per Employee	KRW 91.4M
Profitable Quarters	KRW 4
Profitable Years	4
ROA	10.78
Roa5y	7.22
ROCE	24.55
ROE	27.63
Roe5y	13.76
ROIC	25.28
Roic5y	13.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.75%
Cagr15y	7.4%
Cagr1y	19.69%
Cagr20y	5.93%
Cagr3y	-13.19%
Cagr5y	3.05%
Div CAGR10	20.86%
Div CAGR3	22.12%
Div CAGR5	16.7%
EPS Growth	109.1
EPS Growth Qo Q	1.41
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	26.48
FCF Growth	191.35%
FCF Growth Qo Q	181.45%
FCF Growth3 Y	49.74%
FCF Growth5 Y	36.8%
OCF Growth	160.05%
OCF Growth Qo Q	142.91%
OCF Growth10 Y	22.45%
OCF Growth3 Y	32.1%
OCF Growth5 Y	29.91%
Revenue Growth	10.5x
Revenue Growth Q	16.18x
Revenue Growth Qo Q	11.07x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	7.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.31
Assets	KRW 659.9B
Cash	KRW 102.1B
Current Assets	KRW 344.5B
Current Liabilities	KRW 220.6B
Debt	KRW 71.8B
Debt EBITDA	KRW 0.56
Debt Equity	KRW 0.18
Debt FCF	KRW 0.58
Equity	KRW 409.9B
Interest Coverage	24.37
Liabilities	KRW 250B
Long Term Assets	KRW 315.4B
Long Term Liabilities	KRW 29.3B
Net Cash	KRW 30.3B
Net Cash By Market Cap	KRW 4.99
Net Debt EBITDA	KRW -0.24
Net Debt Equity	KRW -0.07
Net Debt FCF	KRW -0.25
Tangible Book Value	KRW 397.7B
Tangible Book Value Per Share	KRW 17,379
WACC	9.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.56
Inventory Turnover	3.74
Net Working Capital	KRW 76.1B
Quick ratio	1
Working Capital	KRW 123.9B
Working Capital Turnover	KRW 7.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	10.27%
Dividend Growth	0%
Dividend Growth Years	9%
Dividend per share	KRW 450
Dividend Years	1
Dividend Yield	1.62%
Ex Div Date	2026-03-31
Last Dividend	KRW 650
Payout Frequency	Annual
Payout Ratio	15.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50.29%
1Y total return	19.68%
200-day SMA	28,430.8
3Y total return	-34.58%
50-day SMA	25,678
50-day SMA vs 200-day SMA	50under200
5Y total return	16.23%
All Time High	82,903.3
All Time High Change	-67.91%
All Time High Date	2016-09-27
All Time Low	1,594.3
All Time Low Change	1,568.44%
All Time Low Date	2000-12-04
ATR	1,148.2
Beta	1.02
Beta1y	0.62
Beta2y	0.51
Ch YTD	4.31
High	26,700
High52	39,250
High52 Date	2026-02-23
High52ch	-32.23%
Low	26,200
Low52	20,700
Low52 Date	2025-10-13
Low52ch	28.5%
Ma50ch	3.59%
Price vs 200-day SMA	-6.44%
RSI	48.55
RSI Monthly	49.8
RSI Weekly	47.77
Sharpe ratio	0.64x
Sharpe Ratio3y	-0.04x
Sharpe Ratio5y	0.16x
Sortino ratio	1.15
Sortino Ratio3y	0.08
Sortino Ratio5y	0.38
Total Return	11.89%
Tr YTD	6.54
Tr15y	191.95%
Tr1m	3.5%
Tr1w	-3.27%
Tr3m	0.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,897,150%
Net Borrowing	-20,838,675,760
Shares Insiders	0.81%
Shares Institutions	8.49%
Shares Out	22,886,936
Shares Qo Q	0.08%
Shares Yo Y	-10.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	77,758.85x
Bv Per Share	17,911.3
CAPEX	KRW -11.7B
Ch10y	-56.03
Ch15y	147.7
Ch1m	3.5
Ch1w	-3.27
Ch1y	17.18
Ch20y	145.3
Ch3m	0.95
Ch3y	-37.84
Ch5y	6.81
Ch6m	-14.74
Change	-0.56%
Change From Open	0.76
Close	26,750
Days Gap	-1.31
Depreciation Amortization	19,491,586,000
Dollar Volume	544,794,600
Earnings Date	2026-11-13
EBIT	KRW 107.8B
EBITDA	KRW 127.3B
EPS	KRW 4,326
F Score	7
FCF	KRW 122.8B
FCF EV Yield	21.28x
FCF Per Share	KRW 5,366
Financing CF	-36,547,666,170
Fiscal Year End	December
Founded	1,945
Graham Number	41753.16383
Graham Upside	56.97
Income Tax	KRW 14B
Investing CF	-65,125,990,270
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Last Split Date	2023-12-27
Last Split Type	Forward
Lynch Fair Value	KRW 108,145
Lynch Upside	306.6
Ma150	28,829.7
Ma150ch	-7.73%
Ma20	27,362.5
Ma20ch	-2.79%
Net CF	33,083,912,060
Next Earnings Date	2026-11-13
Open	26,400
P FCF Ratio	4.95
P OCF Ratio	4.52
Payment Date	2026-04-24
Position In Range	80
Ppne	162,055,434,170
Price Date	2026-09-11
Price EBITDA	KRW 4.77
Ptbv Ratio	1.53
Relative Volume	0.24x
Revenue	820,861,880,420x
Tax By Revenue	1.71x
Tax Rate	12.16%
Tr20y	216.23%
Tr6m	-12.93%
Volume	20,481
Z Score	4.02

Deeper analysis on KRX/001060

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this KRX/001060 report

Is a complete KRX/001060 research report available?

No complete published report is available for krx/001060 (KRX/001060) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/001060 (KRX/001060)

Korea Stock Exchange: KRX/001060 · KRW

₩26,600

-149.80 (-0.6%)· Recorded snapshot

Market cap	607.4B
Revenue (ttm)	820.9B
Net income (ttm)	97.5B
EPS (ttm)	₩4,326
Shares out	22.9M
P/E (trailing)	6.1x
Dividend	₩450 (1.62%)
Volume	20,481
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 820.9B
Net income (ttm): 97.5B
EPS (ttm): ₩4,326
P/E (trailing): 6.1x
Market cap: 607.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/En/a

P25 7.2P50 11.3P75 24.4

Trailing P/E6.1

P25 7.9P50 14.3P75 25.9

ROE27.6

P25 -16.6P50 0.8P75 9.3

ROIC25.3

P25 -10.2P50 1.4P75 6.7

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All KRX/001060 indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

KRW

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	1,067
Enterprise value	KRW 577.1B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	20.54
Industry PE Fwd	20.3
Isin	KR7001060003
Last refreshed	2026-09-13
Market cap	KRW 607.4B
Price	KRW 26,600
Price currency	KRW
Rev Per Employee	769,317,601.14x
Sector	Healthcare
Sector PE	52.81
Sector PE Fwd	27.79
Sic	2834
Symbol	krx/001060
Website	https://www.jw-pharma.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	16.06%
EV Earnings	5.92x
EV/EBIT	5.24x
EV/EBITDA	4.45x
EV/FCF	4.7x
EV/Sales	0.7x
FCF yield	20.22%
P/B ratio	1.48x
P/E ratio	6.15x
P/S ratio	0.74x
PE Ratio3 Y	13.68x
PE Ratio5 Y	23.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.13%
EBITDA Margin	15.51%
FCF margin	14.96%
Gross margin	47.29%
Gross Profit	KRW 388.2B
Gross Profit Growth	12.79%
Gross Profit Growth Q	16.14%
Gross Profit Growth3 Y	6.9%
Gross Profit Growth5 Y	13.09%
Net Income	KRW 97.5B
Net Income Growth	94.6%
Net Income Growth Qo Q	1.49%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	25.11%
Pretax Margin	14.05%
Profit Margin	12.34%
Profit Per Employee	KRW 91.4M
Profitable Quarters	KRW 4
Profitable Years	4
ROA	10.78
Roa5y	7.22
ROCE	24.55
ROE	27.63
Roe5y	13.76
ROIC	25.28
Roic5y	13.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.75%
Cagr15y	7.4%
Cagr1y	19.69%
Cagr20y	5.93%
Cagr3y	-13.19%
Cagr5y	3.05%
Div CAGR10	20.86%
Div CAGR3	22.12%
Div CAGR5	16.7%
EPS Growth	109.1
EPS Growth Qo Q	1.41
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	26.48
FCF Growth	191.35%
FCF Growth Qo Q	181.45%
FCF Growth3 Y	49.74%
FCF Growth5 Y	36.8%
OCF Growth	160.05%
OCF Growth Qo Q	142.91%
OCF Growth10 Y	22.45%
OCF Growth3 Y	32.1%
OCF Growth5 Y	29.91%
Revenue Growth	10.5x
Revenue Growth Q	16.18x
Revenue Growth Qo Q	11.07x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	7.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 1.31
Assets	KRW 659.9B
Cash	KRW 102.1B
Current Assets	KRW 344.5B
Current Liabilities	KRW 220.6B
Debt	KRW 71.8B
Debt EBITDA	KRW 0.56
Debt Equity	KRW 0.18
Debt FCF	KRW 0.58
Equity	KRW 409.9B
Interest Coverage	24.37
Liabilities	KRW 250B
Long Term Assets	KRW 315.4B
Long Term Liabilities	KRW 29.3B
Net Cash	KRW 30.3B
Net Cash By Market Cap	KRW 4.99
Net Debt EBITDA	KRW -0.24
Net Debt Equity	KRW -0.07
Net Debt FCF	KRW -0.25
Tangible Book Value	KRW 397.7B
Tangible Book Value Per Share	KRW 17,379
WACC	9.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.56
Inventory Turnover	3.74
Net Working Capital	KRW 76.1B
Quick ratio	1
Working Capital	KRW 123.9B
Working Capital Turnover	KRW 7.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	10.27%
Dividend Growth	0%
Dividend Growth Years	9%
Dividend per share	KRW 450
Dividend Years	1
Dividend Yield	1.62%
Ex Div Date	2026-03-31
Last Dividend	KRW 650
Payout Frequency	Annual
Payout Ratio	15.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50.29%
1Y total return	19.68%
200-day SMA	28,430.8
3Y total return	-34.58%
50-day SMA	25,678
50-day SMA vs 200-day SMA	50under200
5Y total return	16.23%
All Time High	82,903.3
All Time High Change	-67.91%
All Time High Date	2016-09-27
All Time Low	1,594.3
All Time Low Change	1,568.44%
All Time Low Date	2000-12-04
ATR	1,148.2
Beta	1.02
Beta1y	0.62
Beta2y	0.51
Ch YTD	4.31
High	26,700
High52	39,250
High52 Date	2026-02-23
High52ch	-32.23%
Low	26,200
Low52	20,700
Low52 Date	2025-10-13
Low52ch	28.5%
Ma50ch	3.59%
Price vs 200-day SMA	-6.44%
RSI	48.55
RSI Monthly	49.8
RSI Weekly	47.77
Sharpe ratio	0.64x
Sharpe Ratio3y	-0.04x
Sharpe Ratio5y	0.16x
Sortino ratio	1.15
Sortino Ratio3y	0.08
Sortino Ratio5y	0.38
Total Return	11.89%
Tr YTD	6.54
Tr15y	191.95%
Tr1m	3.5%
Tr1w	-3.27%
Tr3m	0.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,897,150%
Net Borrowing	-20,838,675,760
Shares Insiders	0.81%
Shares Institutions	8.49%
Shares Out	22,886,936
Shares Qo Q	0.08%
Shares Yo Y	-10.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	77,758.85x
Bv Per Share	17,911.3
CAPEX	KRW -11.7B
Ch10y	-56.03
Ch15y	147.7
Ch1m	3.5
Ch1w	-3.27
Ch1y	17.18
Ch20y	145.3
Ch3m	0.95
Ch3y	-37.84
Ch5y	6.81
Ch6m	-14.74
Change	-0.56%
Change From Open	0.76
Close	26,750
Days Gap	-1.31
Depreciation Amortization	19,491,586,000
Dollar Volume	544,794,600
Earnings Date	2026-11-13
EBIT	KRW 107.8B
EBITDA	KRW 127.3B
EPS	KRW 4,326
F Score	7
FCF	KRW 122.8B
FCF EV Yield	21.28x
FCF Per Share	KRW 5,366
Financing CF	-36,547,666,170
Fiscal Year End	December
Founded	1,945
Graham Number	41753.16383
Graham Upside	56.97
Income Tax	KRW 14B
Investing CF	-65,125,990,270
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Last Split Date	2023-12-27
Last Split Type	Forward
Lynch Fair Value	KRW 108,145
Lynch Upside	306.6
Ma150	28,829.7
Ma150ch	-7.73%
Ma20	27,362.5
Ma20ch	-2.79%
Net CF	33,083,912,060
Next Earnings Date	2026-11-13
Open	26,400
P FCF Ratio	4.95
P OCF Ratio	4.52
Payment Date	2026-04-24
Position In Range	80
Ppne	162,055,434,170
Price Date	2026-09-11
Price EBITDA	KRW 4.77
Ptbv Ratio	1.53
Relative Volume	0.24x
Revenue	820,861,880,420x
Tax By Revenue	1.71x
Tax Rate	12.16%
Tr20y	216.23%
Tr6m	-12.93%
Volume	20,481
Z Score	4.02

Deeper analysis on KRX/001060

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this KRX/001060 report

Is a complete KRX/001060 research report available?

No complete published report is available for krx/001060 (KRX/001060) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

KRX/001060 (KRX/001060)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/001060

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/001060 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on KRX/001060

Frequently asked questions

KRX/001060 (KRX/001060)

Price

Financial snapshot

Fair-value bridge

Latest news · KRX/001060

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRX/001060 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on KRX/001060

Frequently asked questions